Medical
The company said more than 3,800 surgeries had been done with SSi Mantra, including over 200 heart operations.
A dated step forward on the record · Company-reported · Sets SSi Mantra's stage
What the source says
“Over 3,800 surgeries have been performed, including over 200 robotic cardiac surgeries.”
What it means
SSi Mantra, from SS Innovations, is at stage 4 of 5 on our ladder: paying customers. This event is one of the milestones that placed it there. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: Our sources report it working without human help.
More on SSi Mantra
- SS Innovations installed 30 new robots in April to June 2026, bringing the total to 224 in 12 countries and more than 12,200 surgeries.
- The company's CEO, in Georgetown, Guyana, did part of a heart operation on a patient in Indore, India, about 12,500 miles away, with surgeons at the patient's bedside.
- SS Innovations raised $18.6 million by selling shares privately, to prepare for the US and EU markets.
- SS Innovations sent SSi Mantra to the FDA for review under the 510(k) route, covering general, urology, bowel, gynecology and heart surgery. It is not yet cleared.
- Surgeons used SSi Mantra for remote operations on an animal 5 km away, the company's first telesurgery.
- SS Innovations, which already had approval from Indian regulators, filled its first order outside India: a robot for Aster Hospital in Dubai.